47644 Federal Register / Vol. 86, No. 163 / Thursday, August 26, 2021 / Notices 

Filed Date: 8/19/21. 

Accession Number: 20210819–5211. 

Comment Date: 5 pm ET 9/9/21. 

Docket Numbers: ER21–2728–000. 

Applicants: California Independent 

System Operator Corporation. 

Description: § 205(d) Rate Filing: 

2021–08–20 PLA No. 4 Time Ext— 

CDWR to be effective 11/1/2021. 

Filed Date: 8/20/21. 

Accession Number: 20210820–5120. 

Comment Date: 5 pm ET 9/10/21. 

Docket Numbers: ER21–2729–000. 

Applicants: Black Hills Power, Inc. 

Description: § 205(d) Rate Filing: 

Update to Schedule 2 of the Joint Open 

Access Transmission Tariff to be 

effective 10/19/2021. 

Filed Date: 8/20/21. 

Accession Number: 20210820–5130. 

Comment Date: 5 pm ET 9/10/21. 

Docket Numbers: ER21–2730–000. 

Applicants: Unitil Energy Systems, 

Inc. 

Description: § 205(d) Rate Filing: 

Interim Distribution Wheeling 

Agreement with Briar Hydro to be 

effective 8/23/2021. 

Filed Date: 8/20/21. 

Accession Number: 20210820–5132. 

Comment Date: 5 pm ET 9/10/21. 

Take notice that the Commission 

received the following electric securities 

filings: 

Docket Numbers: ES21–65–000. 

Applicants: Interstate Power and 

Light Company. 

Description: Application Under 

Section 204 of the Federal Power Act for 

Authorization to Issue Securities of 

Interstate Power and Light Company. 

Filed Date: 8/18/21. 

Accession Number: 20210818–5170. 

Comment Date: 5 pm ET 9/8/21. 

The filings are accessible in the 

Commission’s eLibrary system (https://

elibrary.ferc.gov/idmws/search/ 

fercgensearch.asp) by querying the 

docket number. 

Any person desiring to intervene or 

protest in any of the above proceedings 

must file in accordance with Rules 211 

and 214 of the Commission’s 

Regulations (18 CFR 385.211 and 

385.214) on or before 5:00 p.m. Eastern 

time on the specified comment date. 

Protests may be considered, but 

intervention is necessary to become a 

party to the proceeding. 

eFiling is encouraged. More detailed 

information relating to filing 

requirements, interventions, protests, 

service, and qualifying facilities filings 

can be found at: http://www.ferc.gov/ 

docs-filing/efiling/filing-req.pdf. For 

other information, call (866) 208–3676 

(toll free). For TTY, call (202) 502–8659. 

Dated: August 20, 2021. 

Kimberly D. Bose, 

Secretary. 

[FR Doc. 2021–18376 Filed 8–25–21; 8:45 am] 

BILLING CODE 6717–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meetings 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of five AHRQ 

subcommittee meetings. 

SUMMARY: The subcommittees listed 

below are part of AHRQ’s Health 

Services Research Initial Review Group 

Committee. Grant applications are to be 

reviewed and discussed at these 

meetings. Each subcommittee meeting 

will be closed to the public. 

DATES: See below for dates of meetings: 

1. Healthcare Effectiveness and 

Outcomes Research (HEOR) 

Date: October 13–14, 2021 

2. Healthcare Safety and Quality 

Improvement Research (HSQR) 

Date: October 13–14, 2021 

3. Health Care Research and Training 

(HCRT) 

Date: October 14–15, 2021 

4. Health System and Value Research 

(HSVR) 

Date: October 14–15, 2021 

5. Healthcare Information Technology 

Research (HITR) 

Date: October 21–22, 2021 

ADDRESSES: Agency for Healthcare 

Research and Quality (Virtual Review), 

5600 Fishers Lane, Rockville, Maryland 

20857. 

FOR FURTHER INFORMATION CONTACT: (To 

obtain a roster of members, agenda or 

minutes of the non-confidential portions 

of the meetings.) 

Jenny Griffith, Committee 

Management Officer, Office of 

Extramural Research Education and 

Priority Populations, Agency for 

Healthcare Research and Quality 

(AHRQ), 5600 Fishers Lane, Rockville, 

Maryland 20857, Telephone (301) 427– 

1557. 

SUPPLEMENTARY INFORMATION: In 

accordance with section 10(a)(2) of the 

Federal Advisory Committee Act (5 

U.S.C. app. 2), AHRQ announces 

meetings of the above-listed scientific 

peer review groups, which are 

subcommittees of AHRQ’s Health 

Services Research Initial Review Group 

Committee. The subcommittee meetings 

will be closed to the public in 

accordance with the provisions set forth 

in 5 U.S.C. app. 2 section 10(d), 5 U.S.C. 

552b(c)(4), and 5 U.S.C. 552b(c)(6). The 

grant applications and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Agenda items for these meetings are 

subject to change as priorities dictate. 

Dated: August 18, 2021. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2021–18428 Filed 8–25–21; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2021–0089] 

Advisory Committee on Immunization 

Practices (ACIP); Amended Notice of 

Meeting 

AGENCY: Centers for Disease Control and 

Prevention, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. Time will be available for public 

comment. The meeting will be webcast 

live via the World Wide Web; for more 

information on ACIP please visit the 

ACIP website: http://www.cdc.gov/ 

vaccines/acip/index.html. 

DATES: The meeting will be held on 

August 30, 2021 and August 31, 2021, 

from 10:00 a.m. to 4:00 p.m., EDT (times 

subject to change). The docket is 

currently open to receive written 

comments. Written comments must be 

received on or before August 31, 2021. 

A notice of this ACIP meeting has also 

been posted on CDC’s ACIP website at: 

http://www.cdc.gov/vaccines/acip/ 

index.html. In addition, CDC has sent 

notice of this ACIP meeting by email to 

those who subscribe to receive email 

updates about ACIP. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0089 by any of the following methods: 


jbell on DSKJLSW7X2PROD with NOTICES